ATE185814T1 - Aus neuen e.coli stämmen isolierte typ 1 und typ p fibrillen-adhesine, verfahren zu ihrer herstellung und ihre verwendungen - Google Patents
Aus neuen e.coli stämmen isolierte typ 1 und typ p fibrillen-adhesine, verfahren zu ihrer herstellung und ihre verwendungenInfo
- Publication number
- ATE185814T1 ATE185814T1 AT95200257T AT95200257T ATE185814T1 AT E185814 T1 ATE185814 T1 AT E185814T1 AT 95200257 T AT95200257 T AT 95200257T AT 95200257 T AT95200257 T AT 95200257T AT E185814 T1 ATE185814 T1 AT E185814T1
- Authority
- AT
- Austria
- Prior art keywords
- type
- fimbriae
- adhesins
- coli strains
- fibril
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 239000012506 Sephacryl® Substances 0.000 abstract 1
- 229920002684 Sepharose Polymers 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000013049 sediment Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Paints Or Removers (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09400202A ES2076895B1 (es) | 1994-02-04 | 1994-02-04 | Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE185814T1 true ATE185814T1 (de) | 1999-11-15 |
Family
ID=8285106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95200257T ATE185814T1 (de) | 1994-02-04 | 1995-02-02 | Aus neuen e.coli stämmen isolierte typ 1 und typ p fibrillen-adhesine, verfahren zu ihrer herstellung und ihre verwendungen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0666271B1 (de) |
| JP (1) | JP2851556B2 (de) |
| AT (1) | ATE185814T1 (de) |
| AU (1) | AU691221B2 (de) |
| BR (1) | BR9500546A (de) |
| CA (1) | CA2141475C (de) |
| DE (1) | DE69512808T2 (de) |
| DK (1) | DK0666271T3 (de) |
| ES (1) | ES2076895B1 (de) |
| GR (1) | GR3032332T3 (de) |
| PT (1) | PT666271E (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1328641A2 (de) * | 2000-03-10 | 2003-07-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Polynukleotidem aus b2/d+ a- e. coli und deren verwndungen |
| EP1342784A1 (de) * | 2002-03-06 | 2003-09-10 | Mutabilis S.A. | ExPEC-spezifische Proteine, entsprechende Gene und ihre Verwendungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA836349B (en) * | 1982-09-02 | 1985-04-24 | Unilever Plc | Production of antibodies |
| DK41885A (da) * | 1985-01-31 | 1986-11-13 | Slagteriernes Forskningsinst | 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen |
| US4725435A (en) * | 1986-06-18 | 1988-02-16 | Bactex, Inc. | Vaccine composition for immunization against urinary tract infection caused by E. coli |
| WO1990000614A1 (en) * | 1988-07-13 | 1990-01-25 | Baylor College Of Medicine | Receptor specific proteins and their use in receptor typing |
| DE3832785A1 (de) * | 1988-09-27 | 1990-04-19 | Max Planck Gesellschaft | Verfahren zur gewinnung von p-adhaesin |
-
1994
- 1994-02-04 ES ES09400202A patent/ES2076895B1/es not_active Expired - Fee Related
-
1995
- 1995-01-31 CA CA002141475A patent/CA2141475C/en not_active Expired - Fee Related
- 1995-02-01 AU AU11503/95A patent/AU691221B2/en not_active Ceased
- 1995-02-02 DE DE69512808T patent/DE69512808T2/de not_active Expired - Fee Related
- 1995-02-02 EP EP95200257A patent/EP0666271B1/de not_active Expired - Lifetime
- 1995-02-02 AT AT95200257T patent/ATE185814T1/de not_active IP Right Cessation
- 1995-02-02 PT PT95200257T patent/PT666271E/pt unknown
- 1995-02-02 DK DK95200257T patent/DK0666271T3/da active
- 1995-02-03 JP JP7016819A patent/JP2851556B2/ja not_active Expired - Fee Related
- 1995-02-06 BR BR9500546A patent/BR9500546A/pt not_active Application Discontinuation
-
2000
- 2000-01-12 GR GR20000400030T patent/GR3032332T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2076895B1 (es) | 1996-08-16 |
| JPH0834798A (ja) | 1996-02-06 |
| AU691221B2 (en) | 1998-05-14 |
| DE69512808T2 (de) | 2000-06-15 |
| CA2141475A1 (en) | 1995-08-05 |
| PT666271E (pt) | 2000-04-28 |
| DK0666271T3 (da) | 2000-04-17 |
| CA2141475C (en) | 1999-08-24 |
| GR3032332T3 (en) | 2000-04-27 |
| AU1150395A (en) | 1995-08-17 |
| JP2851556B2 (ja) | 1999-01-27 |
| DE69512808D1 (de) | 1999-11-25 |
| EP0666271B1 (de) | 1999-10-20 |
| ES2076895A1 (es) | 1995-11-01 |
| EP0666271A1 (de) | 1995-08-09 |
| BR9500546A (pt) | 1997-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10195314B2 (en) | Fractionation of charged keratin | |
| KR102611970B1 (ko) | 히알루론산의 정제 공정 | |
| ES2811101T3 (es) | Procedimiento para la preparación y purificación de la sal de sodio de ácido hialurónico | |
| DK1856272T3 (da) | Anvendelse af fremstillet produkt og fremgangsmåde til fremstilling af kollagenopløsning og fremgangsmåde til kollagenseparation af dyrevæv | |
| DE69034261D1 (de) | Antikörper gegen VLA-4 | |
| HUP0003013A2 (hu) | Eljárás és készítmények késői fázisban lévő allergiás reakciók és gyulladásos megbetegedések kezelésére | |
| BR0108386C1 (pt) | urato oxidase purificada (uricase), conjugado de uricase, composição farmacêutica para reduzir os nìveis de ácido úrico nos fluidos ou tecidos corporais, método para a purificação de uricase dotada de imunogenicidade reduzida | |
| KR0131204B1 (ko) | 암 면역치료용 보조제 | |
| ATE185814T1 (de) | Aus neuen e.coli stämmen isolierte typ 1 und typ p fibrillen-adhesine, verfahren zu ihrer herstellung und ihre verwendungen | |
| ATE206285T1 (de) | Verfahren zur herstellung von kolostralmilchprodukten sowie deren verwendung | |
| HUT75557A (en) | Heparin-binding protein for the treatment of sepsis and processes for its preparation | |
| Carmichael | Recent developments in hemoglobin-based oxygen carriers–an update on clinical trials | |
| CN1286262A (zh) | 人胎盘抗凝蛋白介导的新型抗凝蛋白 | |
| DE69724328T2 (de) | Konjugate von einem Interleukin-2 Rezeptor spezifisch erkennenden Faktor mit Ribonuklease | |
| JPH0265790A (ja) | 免疫賦活作用を有する粗糖蛋白質画分及びその製造法 | |
| WO2002030887A3 (en) | Protein having thrombolytic activities extracted from natural product | |
| Carlstedt | Mucus glycoprotein: Structure and macromolecular properties. | |
| JPS6163293A (ja) | ヒアルロン酸の製造法 | |
| SE9904066D0 (sv) | Steril, icke-antigen hyaluronsyralösning och användning därav | |
| Reese | NEW COLLAGENOUS COMPONENTS OF CHICKEN HYALINE CARTILAGE. | |
| JPS62292800A (ja) | 生物活性を有する金属タンパク質複合体およびその製法 | |
| JPS62190128A (ja) | 腫瘍細胞増殖抑制および殺腫瘍細胞因子の製造法 | |
| Frankel | Expression of actin in Escherichia coli, its preparation in a soluble form, and its functional characterization. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |